Pages that link to "Q35531853"
Jump to navigation
Jump to search
The following pages link to Synthetic metallochaperone ZMC1 rescues mutant p53 conformation by transporting zinc into cells as an ionophore (Q35531853):
Displaying 20 items.
- Targeting Oncogenic Mutant p53 for Cancer Therapy (Q26770856) (← links)
- Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer (Q26800059) (← links)
- Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. (Q27333756) (← links)
- The beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53-carrying colorectal cancer cells (Q35986990) (← links)
- Zn(II)-curc targets p53 in thyroid cancer cells (Q36094135) (← links)
- The biological inorganic chemistry of zinc ions. (Q37433265) (← links)
- Thiosemicarbazones Functioning as Zinc Metallochaperones to Reactivate Mutant p53. (Q38711481) (← links)
- Reviving the guardian of the genome: Small molecule activators of p53. (Q39205536) (← links)
- Targeting mutant p53 for efficient cancer therapy. (Q47291772) (← links)
- Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others (Q47742599) (← links)
- The Crystal Structure of the R280K Mutant of Human p53 Explains the Loss of DNA Binding. (Q52322370) (← links)
- Zinc Metallochaperones as Mutant p53 Reactivators: A New Paradigm in Cancer Therapeutics. (Q55471290) (← links)
- Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target. (Q55515721) (← links)
- Therapeutic targeting of and mutant breast cancer through mutant p53 reactivation (Q64114526) (← links)
- Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket (Q64231035) (← links)
- Flipping the "switch" on mutant p53 by zinc metallochaperones: how a brief pulse of zinc can reactivate mutant p53 to kill cancer (Q64235749) (← links)
- Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics (Q89142948) (← links)
- Bifunctional ligand design for modulating mutant p53 aggregation in cancer (Q89703505) (← links)
- Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper Binding (Q92731843) (← links)
- Pharmacological targeting of mutant p53 (Q92914764) (← links)